SCHEMBL24310755

SCHEMBL24310755

Clc1cc(Oc2ccccc2)nc(NSc2ccccc2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
MEN1 O00255 3/20 0.40
KMT2A Q03164 3/20 0.40
GPR39 O43194 1/20 0.39
HTT P42858 2/20 0.38
MAPK1 P28482 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
NUDT1 P36639 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.36
HPGD P15428 2/20 0.36
ATM Q13315 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
LMNA P02545 5/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ALDH1A1 P00352 3/20 0.35
RAB9A P51151 1/20 0.35
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310446 0.90 MAPT (0.46) MAPTCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL24309777 0.85 LMNA (0.38) MAPTCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL24309787 0.83 MAPT (0.36) MAPTCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL24309748 0.83 L3MBTL1 (0.38) MAPTCYP1A2MEN1KMT2AHTT
SCHEMBL24309752 0.82 MAPK1 (0.57) MAPTCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL24309620 0.80 MAPT (0.41) MAPTCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL24309989 0.79 MAPT (0.40) MAPTCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL24309979 0.78 MAPT (0.40) MAPTCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL24310308 0.75 KDM4E (0.50) MAPTCYP1A2CYP2C9CYP2C19MEN1
SCHEMBL24309299 0.74 TSHR (0.56) MAPTCYP1A2CYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 WO disclosed